Non Cystic Fibrosis Bronchiectasis: Clinical Trials

4 trials for Non Cystic Fibrosis Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1

Follow Non Cystic Fibrosis Bronchiectasis: new trials by email Literature Review of Non Cystic Fibrosis Bronchiectasis trials Research Report on Non Cystic Fibrosis Bronchiectasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.
CMS, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3TerminatedZambon SpA2872018-01-292026-10-15
Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)
CMS, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedZambon SpA3772017-06-062023-11-15
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)
Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedAradigm Corporation3042014-05-282021-03-26
Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)
Ciprofloxacin dispersion for inhalation, Placebo - Non Cystic Fibrosis Bronchiectasis
Phase 3CompletedAradigm Corporation2782014-03-312021-03-26

Narrower conditions

Bronchiectasis (2)  ·  Pseudomonas Infections (1)

Broader conditions

Bronchial Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Infections (1)

Interventions

Inhalation (2)  ·  Saline Solution (2)  ·  colistinmethanesulfonic acid (1)

Sponsors

Aradigm Corporation (2)  ·  Zambon SpA (2)

Countries

Australia (4)  ·  Israel (4)  ·  Italy (4)  ·  Canada (3)  ·  Germany (3)  ·  New Zealand (3)  ·  Poland (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  United States (3)  ·  France (2)  ·  Greece (2)  ·  Hungary (2)  ·  Portugal (2)  ·  Romania (2)

Top investigators

Paola Castellani, MD (1)

Results publications

PMID 30658914, PMID 32554534

NIH funding

2015 (1), 2016 (1)